Social Enterprise that provides Medical Research and Services focused on improving the Diagnosis, Treatment and Care of Chronic Disease.
Oakington, Cambridge
Joined April 2015
- Tweets282
- Following187
- Followers150
- Likes25
We are delighted to be collaborating with Pangaea Data @PangaeaDataAI to turn AI-powered insights into measurable improvements in patient care.
Read more: lnkd.in/eC2VMBfJ
#HealthcareAI #PatientOutcomes #DigitalHealth
Study of over 9,000 patients with severe asthma links easier access to biologic therapies with better asthma outcomes, including clinical remission.
Full Publication: lnkd.in/gH4pquJV
Press Release: lnkd.in/gjyXrXjE
We’ve launched our new sustainability page, sharing how we’re building a responsible, ethical and sustainable organisation across environment, people, communities, supply chains and governance.
View here: opcglobal.org/sustainability
#Sustainability #ESG #ResponsibleBusiness
Did you know it takes over 10 years to diagnose Bronchiectasis? This under-recognized lung condition affects hundreds of thousands worldwide. Earlier diagnosis = earlier treatment.
Read more: lnkd.in/gerfw_RJ
#WorldBronchiectasisDay #Bronchiectasis #WBD2026
New RESA e-tool enables personalised prediction of severe asthma attacks, supporting clinicians with data-driven decisions
Full Publication: lnkd.in/g56dTW3H
Press Release: lnkd.in/g5Tiw5PF
New ISAR data shows Greek patients with severe asthma have fewer exacerbations and steroid-related diseases vs global rates, while highlighting key opportunities to enhance patient care
Full Publication: lnkd.in/gTc7J5NH
Press Release: lnkd.in/gvfuvuYV
On #WorldAsthmaDay 2026, we’re highlighting the importance of better asthma care for all.
Read our latest blog:
isar.opcglobal.org/post/worl…
#WorldAsthmaDay #AsthmaAwareness #RespiratoryHealth #SevereAsthma #ISAR #RealWorldData #OPC
ISAR Study: Real-world data and RCTs share common downstream pathways (IgE→BEC, prior attacks) predicting severe asthma exacerbations, while real-world data reveal broader upstream pathways for risk modification
Press: lnkd.in/gS4aVJy4
Publication: lnkd.in/gxBfTspJ
New study shows Mexican severe asthma patients use fewer long-term steroids and have fewer related conditions, but higher exacerbations and poorer control highlighting need for earlier, targeted care.
Press release: lnkd.in/guEFZ9Bp
Full article : lnkd.in/gzfrdp-7
Optimum Patient Care retweeted
OPRI led real-world study with @hospital_hvn @FacMedicinaUGR suggests GLP-1 RAs may cut COPD exacerbations & steroid use, a new insight for complex cardiometabolic care.
Press Release: lnkd.in/gHbiJycK
Full Article: lnkd.in/gkHR82in
#COPD #Obesity #GLP1RA #OPCRD
Optimum Patient Care retweeted
A new study from OPRI demonstrates that long-term cardiovascular and respiratory risks can be predicted in people with COPD using routinely collected primary care data.
Press release: lnkd.in/gnP2QN8u
Full article : lnkd.in/gMqHgDYf
#COPD #CardioRespiratory #OPCRD
New Australian real-world research shows that a quality-improvement program (ACAER) in primary care significantly reduces asthma and COPD exacerbations.
Press Release: tinyurl.com/ACAER-Press-Rele…
Full Article: tinyurl.com/ACAER-Read-Full-…
#OPCRDA #PrimaryCare #Asthma #COPD
Real-world EMBER study shows T2 biologics improve outcomes across all asthma clusters, incl. T2-low, but better treatments still needed.
Full Publication: bit.ly/Full-Publication
Press Release: bit.ly/EMBER-Press-Release
#SevereAsthma #Biologics #Biomarkers #ISAR
Title: Prediction pathway for severe asthma exacerbations: a Bayesian Network analysis.
Yadav C P 𝘦𝘵 𝘢𝘭.
Article: doi.org/10.1016/j.chest.2025…
Press Release: isar.opcglobal.org/post/crac…
#PredictionPathway #ISAR
𝐒𝐓𝐀𝐑 𝐬𝐭𝐮𝐝𝐲: Disease burden was high in severe asthma patients using 𝐋𝐓𝐎𝐂𝐒, irrespective of 𝐁𝐄𝐂.
𝘚𝘤𝘩𝘭𝘦𝘪𝘤𝘩 𝘍 𝘦𝘵 𝘢𝘭.
Article: tin.al/STARstudy-Fulltext
Press Release: tin.al/STARstudy-PressReleas…
Open access license: tin.al/OpenAccessLicense
#STARstudy #ISAR
Powerful real-world evidence on severe asthma patients:
SOLAR II: Biologics prevent systemic complications of steroid use.
Full article:tin.al/SOLAR-II-FullText
Press release: tin.al/SOLAR-II-PressRelease
#SevereAsthma #Biologics #OralCorticosteroids #Research
Powerful real-world evidence on severe asthma patients:
SOLAR I: Biologics minimize steroid exposure.
Full article: tin.al/SOLAR-I-FullText
Press release: tin.al/SOLAR-I-PressRelease
#SevereAsthma #Biologics #OralCorticosteroids #Research
SOLAR II study highlights a major breakthrough in asthma care! Biologics show promise in preventing diabetes, MACE, and other OCS-related adverse outcomes. A game-changer in respiratory treatment!📖Read the full article: atsjournals.org/doi/abs/10.1… #Asthma #Biologics #SOLARII
We're excited to be among 19 organizations supported by Health Data Research UK to adopt the #UKHealthDataResearchAlliance Transparency Standards. This helps us enhance access to our work with OPCRD for researchers and the public. #TransparentDataAccess
wix.to/dVl2rSg
Optimum Patient Care retweeted
🤔 How well is information on data access processes shared with the public?
Our Public Advisory Board reviewed 70 #UKHealthDataResearchAlliance members’ websites to recommend ways to improve #TransparentDataAccess.
Read Alan’s blog post to learn more ⬇️
hubs.li/Q02wQx6m0